Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mereo Biopharma Group Plc (DE:MAH0)
STUTTGART:MAH0
RESEARCH TOOLSreports
Mereo Biopharma Group Plc (MAH0) Stock Price & Analysis
0 Followers
MAH0 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.87 - €4.00
Previous Close€2.83
Volume0.00
Average Volume (3M)1.83K
Market Cap
€28.17M
Enterprise Value-€22.77M
Total Cash (Recent Filing)£56.33M
Total Debt (Recent Filing)£12.77M
Price to Earnings (P/E)N/A
Beta-1.24
Next Earnings
Sep 17, 2024EPS Estimate
>-€0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,835
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€5.59Price Target Upside97.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Mereo Biopharma Group Plc News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.04% Other Institutional Investors
99.96% Public Companies and
Individual Investors
MAH0 FAQ
What was Mereo Biopharma Group Plc’s price range in the past 12 months?
Mereo Biopharma Group Plc lowest stock price was €0.87 and its highest was €4.00 in the past 12 months.
What is Mereo Biopharma Group Plc’s market cap?
Currently, no data Available
When is Mereo Biopharma Group Plc’s upcoming earnings report date?
Mereo Biopharma Group Plc’s upcoming earnings report date is Sep 17, 2024 which is in 135 days.
How were Mereo Biopharma Group Plc’s earnings last quarter?
Mereo Biopharma Group Plc released its earnings results on Mar 27, 2024. The company reported -€0.019 earnings per share for the quarter, the consensus estimate of -€0.019 by €0.
Is Mereo Biopharma Group Plc overvalued?
According to Wall Street analysts Mereo Biopharma Group Plc’s price is currently Undervalued.
Does Mereo Biopharma Group Plc pay dividends?
Mereo Biopharma Group Plc does not currently pay dividends.
What is Mereo Biopharma Group Plc’s EPS estimate?
Mereo Biopharma Group Plc’s EPS estimate is >-€0.01.
How many shares outstanding does Mereo Biopharma Group Plc have?
Currently, no data Available
What happened to Mereo Biopharma Group Plc’s price movement after its last earnings report?
Mereo Biopharma Group Plc reported an EPS of -€0.019 in its last earnings report, expectations of -€0.019. Following the earnings report the stock price went up 12.782%.
Which hedge fund is a major shareholder of Mereo Biopharma Group Plc?
Among the largest hedge funds holding Mereo Biopharma Group Plc’s share is PRIMECAP Management Co. It holds Mereo Biopharma Group Plc’s shares valued at 125K.
---
Mereo Biopharma Group Plc Stock Smart Score
Company Description
Mereo Biopharma Group Plc
Mereo BioPharma Group Plc engages in the acquisition, development, and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare and specialty diseases. It focuses on the treatment of patients with Osteogenesis Imperfecta, Alpha-1 Antitrypsin Deficiency, Hypogonadotropic Hypogonadism in obese men, and Acute Exacerbations of Chronic Obstructive Pulmonary Disease. The company was founded by Denise Vera Pollard-Knight, Charles Sermon, Alastair MacKinnon, and John Richard in March 2015 and is headquartered in London, the United Kingdom.
---
MAH0 Stock 12 Months Forecast
Average Price Target
€5.59
▲(97.46% Upside)
Technical Analysis
Mereo Biopharma Group Plc
―
MacroGenics
―
Molecular Templates
―
Marker Therapeutics
―
Mersana Therapeutics
―
Best Analysts Covering MAH0
1 Year
1 Year Success Rate
10/14 ratings generated profit
1 Year Average Return
+75.43%
reiterated a buy rating last month
Copying Joseph Schwartz's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +75.43% per trade.
---